BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2021

Feb 2, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2021-01-28

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-01-28	Common Stock	M	8333	$26.49	Acquired	303885	Direct
2021-01-28	Common Stock	S	8333	$82.91	Disposed	295552	Direct
2021-01-29	Common Stock	M	8334	$26.49	Acquired	303886	Direct
2021-01-29	Common Stock	S	8334	$82.67	Disposed	295552	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-28	Stock Option (Right to buy Common Stock)	$26.49	M	8333	Disposed	2021-05-11	Common Stock (8333)	Direct
2021-01-29	Stock Option (Right to buy Common Stock)	$26.49	M	8334	Disposed	2021-05-11	Common Stock (8334)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	247533	Indirect

Footnotes

F1: Trade made pursuant to a 10b5-1 plan executed on September 11, 2020.

F2: Reflects the number of options outstanding after the transactions from this specific stock option grant.